AJP - GI AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (October 1, 2009). doi:10.1152/ajpgi.00323.2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Flynn, R. S
Right arrow Articles by Kuemmerle, J. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flynn, R. S
Right arrow Articles by Kuemmerle, J. F.

Research Article

Insulin-like Growth Factor Binding Protein-5 Stimulates Growth of Human Intestinal Muscle Cells by Activation of G{alpha}i3

Robert S Flynn,1 Sunila Mahavadi,1 Karnam S Murthy,1 John M Kellum,2 and John F. Kuemmerle3,*

1Virginia Commonwealth University 2Medical College of Virginia/Virginia Commonwealth University 3Med Col Virginia, VCU

Submitted 4 August 2009 ; revision received 21 September 2009 ; accepted in final form 24 September 2009

ABSTRACT

In human intestinal smooth muscle cells, endogenous Insulin-like Growth Factor-I (IGF-I) regulates growth and IGF binding protein-5 (IGFBP-5) expression. The effects of IGF-I are facilitated by IGFBP-5. We previously showed that IGFBP-5 acts independently of IGF-I in human intestinal muscle to stimulate proliferation and up-regulate IGF-I production by activation of Erk1/2 and p38 MAP kinase. Thus a positive feedback loop exists between IGF-I and IGFBP-5 whereby both stimulate muscle growth and production of the other factor. In Crohn's disease, IGF-I and IGFBP-5 expression are increased and contribute to stricture formation through this effect on muscle growth. To determine the signaling pathways coupling IGFBP-5 to MAP kinase activation and growth, smooth muscle cells were isolated from muscularis propria of human intestine and placed into primary culture. Erk1/2 and p38 MAP kinase activation and Type I collagen production were measured by immunoblot. Proliferation was measured by [3H]thymidine incorporation. Activation of specific G proteins was measured by ELISA. AG1024, an IGF-I receptor tyrosine kinase inhibitor, was used to isolate the IGF-I-independent effects of IGFBP-5. IGFBP-5-induced phosphorylation of Erk1/2 and p38 MAP kinase, and proliferation were abolished by pertussis toxin implying the participation of Gi. IGFBP-5 specifically activated Gi3 but not other G proteins. Transfection of cells with an inhibitory G{alpha}i minigene, but not an inhibitory {gamma} minigene, inhibited MAP kinase activation, proliferation and collagen production. Our results indicate endogenous IGFBP-5 activates Gi3 and regulates smooth muscle growth and collagen production via the {alpha}-subunit of Gi3, independently of IGF-I, in human intestinal muscle cells.

IGFBP-5; smooth muscle cell; heterotrimeric G protein; p38 MAP kinase; Erk1/2



* Med Col Virginia, VCU john.kuemmerle{at}vcu.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.